Plasma Kallikrein Inhibitor [EPC]

1548 reported adverse events

Drugs of this class: ECALLANTIDE

These side effects are most commonly reported by patients taking drugs of the Plasma Kallikrein Inhibitor [EPC] class:

# Side effect Count
0 HEREDITARY ANGIOEDEMA 583
1 OFF LABEL USE 164
2 DRUG INEFFECTIVE 119
3 HEADACHE 69
4 MALAISE 58
5 NAUSEA 58
6 ANAPHYLACTIC REACTION 56
7 HYPERSENSITIVITY 55
8 PAIN 55
9 THERAPEUTIC RESPONSE DECREASED 54
See all common reactions for Plasma Kallikrein Inhibitor [EPC]

Drugs of the Plasma Kallikrein Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HTLV TEST POSITIVE 1 0.1250
1 HEREDITARY ANGIOEDEMA 583 0.1131
2 LARGE CELL LUNG CANCER METASTATIC 1 0.0833
3 FAILED EXAMINATIONS 1 0.0833
4 MASTITIS BACTERIAL 1 0.0833
5 CHEILITIS GRANULOMATOSA 1 0.0526
6 PLICA SYNDROME 1 0.0476
7 LACTATION PUERPERAL INCREASED 1 0.0357
8 VASCULAR ACCESS MALFUNCTION 1 0.0333
9 VASCULAR ACCESS SITE COMPLICATION 1 0.0323
See all enriched reactions for Plasma Kallikrein Inhibitor [EPC]